Article

  • The EMBO Journal (2005) 24, 1863 - 1873
  • doi:10.1038/sj.emboj.7600654

Published online: 5 May 2005

Impaired maturation of myeloid progenitors in mice lacking novel Polycomb group protein MBT-1

Satoko Arai1 and Toru Miyazaki1

  1. Center for Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA

Correspondence to:

Toru Miyazaki, Center for Immunology, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard NA7200, Dallas, TX 75390-9093, USA. Tel.: +1 214 648 7322; Fax: +1 214 648 7331; E-mail: Toru.Miyazaki@UTSouthwestern.edu

Received 23 November 2004; Accepted 31 March 2005


Polycomb group (PcG) proteins participate in DNA-binding complexes with gene-repressing activity, many of which have been highlighted for their involvement in hematopoiesis. We have identified a putative PcG protein, termed MBT-1, that is associated with Rnf2, an in vivo interactor of PcG proteins. MBT-1 structurally resembles the H-L(3)MBT protein, whose deletion is predicted to be responsible for myeloid hematopoietic malignancies. The human MBT-1 gene is located on chromosome 6q23, a region frequently deleted in leukemia cells, and shows a transient expression spike in response to maturation-inducing stimuli in myeloid leukemia cells. MBT-1-/- myeloid progenitor cells exhibit a maturational deficiency but maintain normal proliferative activities. This results in the accumulation of immature myeloid progenitors and hence, a marked decrease of mature myeloid blood cells, causing the MBT-1-/- mice to die of anemia during a late embryonic stage. Together, we conclude that MBT-1 specifically regulates the maturational advancement of myeloid progenitor cells during transitions between two developmental stages. We also show that MBT-1 appears to influence myelopoiesis by transiently enhancing p57KIP2 expression levels.

  • Keywords:

    • cyclin-dependent kinase inhibitor (CDKI),
    • hematopoiesis,
    • mbt repeat,
    • polycomb,
    • Rnf2
Top

MORE ARTICLES LIKE THIS